Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP).
Pharmacol Res
; 166: 105499, 2021 04.
Article
in En
| MEDLINE
| ID: mdl-33607265
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Atherosclerosis
/
Acute Coronary Syndrome
/
Ezetimibe
/
PCSK9 Inhibitors
/
Anticholesteremic Agents
Type of study:
Guideline
Limits:
Humans
Language:
En
Journal:
Pharmacol Res
Journal subject:
FARMACOLOGIA
Year:
2021
Document type:
Article
Country of publication: